Cardiff Oncology Net Debt Growth & History (CRDF)

Cardiff Oncology's net debt was −$16.6M for fiscal 2025.

View full Cardiff Oncology company overview

Cardiff Oncology annual net debt history

Cardiff Oncology annual net debt

Fiscal yearPeriod endedNet debtChangeGrowth
20252025-12-31−$16.6M$33.3M
20242024-12-31−$49.9M−$30.4M
20232023-12-31−$19.5M−$5.9M
20222022-12-31−$13.6M−$4.8M
20212021-12-31−$8.8M$121.3M
20202020-12-31−$130.1M−$121.6M
20192019-12-31−$8.5M$3.0M
20182018-12-31−$11.5M−$3.2M
20172017-12-31−$8.2M−$8.5M
20162016-12-31$261,265$56.5M
20152015-12-31−$56.2M−$42.0M
20142014-12-31−$14.2M

Cardiff Oncology net debt trends

Over the last five fiscal years, Cardiff Oncology's net debt increased from −$130.1M to −$16.6M, a change of $113.5M. The latest reported quarter, Q2 2026, shows −$8.7M.

About the metric

What net debt means

Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.

Calculation and source

How net debt is calculated

TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Cardiff Oncology source filings ↗

Community posts

It’s quiet here.

No posts about CRDF yet. Start the conversation.

Write the first post